Literature DB >> 23801845

Nodular regenerative hyperplasia related portal hypertension in a patient with hypogammaglobulinaemia.

Barun Kumar Lal1, Adrian Stanley.   

Abstract

Nodular regenerative hyperplasia (NRH) of liver is a relatively rare liver disorder, but a frequent cause of noncirrhotic portal hypertension. We present a lady with common variable immune deficiency who presented with upper gastrointestinal bleeding and deranged liver function tests but preserved synthetic function. Upper gastrointestinal endoscope showed bleeding gastric varices and non-bleeding oesophageal varices. Although her oesophageal varices were eradicated by repeated endoscopic band ligation, the gastric varices failed to resolve after repeated endoscopic histocryl injection and she eventually needed transjugular intrahepatic portosystemic shunt placement. Liver biopsy showed NRH. We review the association of hypogammaglobinaemia and NRH and discuss the appropriate management of portal hypertension in NRH.

Entities:  

Keywords:  Gastro-oesophageal varices; Hypogammaglobilinaemia; Liver; Nodular regenerative hyperplasia; Portal hypertension

Mesh:

Substances:

Year:  2013        PMID: 23801845      PMCID: PMC3683691          DOI: 10.3748/wjg.v19.i22.3502

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  12 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

2.  Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.

Authors:  Roberto de Franchis
Journal:  J Hepatol       Date:  2010-06-27       Impact factor: 25.083

Review 3.  Review article: recent advances in the management of bleeding gastric varices.

Authors:  D Tripathi; J W Ferguson; G Therapondos; J N Plevris; P C Hayes
Journal:  Aliment Pharmacol Ther       Date:  2006-07-01       Impact factor: 8.171

4.  Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology.

Authors:  Y Nakanuma; M Hoso; M Sasaki; T Terada; K Katayanagi; A Nonomura; H Kurumaya; A Harada; H Obata
Journal:  Histopathology       Date:  1996-03       Impact factor: 5.087

5.  Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy.

Authors:  T Fukuda; S Hirota; K Sugimura
Journal:  J Vasc Interv Radiol       Date:  2001-03       Impact factor: 3.464

6.  Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities.

Authors:  Georgia Malamut; Marianne Ziol; Felipe Suarez; Michel Beaugrand; Jean François Viallard; Anne Sophie Lascaux; Virginie Verkarre; Dominique Bechade; Thierry Poynard; Olivier Hermine; Christophe Cellier
Journal:  J Hepatol       Date:  2007-10-17       Impact factor: 25.083

Review 7.  Nodular regenerative hyperplasia: a controversial indication for orthotopic liver transplantation.

Authors:  H A Elariny; S S Mizrahi; D H Hayes; J P Boudreaux; J L Hussey; G H Farr
Journal:  Transpl Int       Date:  1994-07       Impact factor: 3.782

8.  Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia.

Authors:  C Ward; M Lucas; J Piris; J Collier; H Chapel
Journal:  Clin Exp Immunol       Date:  2008-07-18       Impact factor: 4.330

9.  Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series.

Authors:  Y Nakanuma
Journal:  J Clin Gastroenterol       Date:  1990-08       Impact factor: 3.062

10.  Human X-linked variable immunodeficiency caused by a hypomorphic mutation in XIAP in association with a rare polymorphism in CD40LG.

Authors:  Stéphanie Rigaud; Eduardo Lopez-Granados; Sophie Sibéril; Geoffrey Gloire; Nathalie Lambert; Christelle Lenoir; Cindy Synaeve; Maria Stacey; Lars Fugger; Jean-Louis Stephan; Alain Fischer; Capucine Picard; Anne Durandy; Helen Chapel; Sylvain Latour
Journal:  Blood       Date:  2011-05-04       Impact factor: 22.113

View more
  3 in total

Review 1.  Idiopathic Non-Cirrhotic Intrahepatic Portal Hypertension (NCIPH)-Newer Insights into Pathogenesis and Emerging Newer Treatment Options.

Authors:  Ashish Goel; Joshua E Elias; Chundamannil E Eapen; Banumathi Ramakrishna; Elwyn Elias
Journal:  J Clin Exp Hepatol       Date:  2014-07-28

2.  Indolent cytotoxic T cell lymphoproliferation associated with nodular regenerative hyperplasia: a common liver lesion in the context of common variable immunodeficiency disorder.

Authors:  Vanessa Szablewski; Céline René; Valérie Costes
Journal:  Virchows Arch       Date:  2015-10-22       Impact factor: 4.064

3.  Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies.

Authors:  Federica Pulvirenti; Ilaria Pentassuglio; Cinzia Milito; Michele Valente; Adriano De Santis; Valentina Conti; Giulia d'Amati; Oliviero Riggio; Isabella Quinti
Journal:  J Immunol Res       Date:  2014-03-31       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.